Jianzhi Education Technology Group enters mid-May with a striking divergence: the cost to short is falling fast, yet the stock itself is losing ground just as quickly.
The most telling move in the lending market is the rapid collapse of borrowing costs. Cost to borrow has fallen to 60.8% — down more than 54% on the week and 71% over the past month. For context, CTB was running above 200% through most of April, briefly touching 230% on April 10. That level pointed to extreme borrow scarcity. The current reading is closer to a normalised expensive-to-borrow rather than a crisis. Availability has tightened slightly, with the borrow pool about two-thirds unused at present — down from a near-total squeeze earlier in the spring, but still reflecting a smaller short position overall.
The short position itself has retreated sharply. Estimated short shares dropped 34% over the week to roughly 9,700 shares, and are down 48% versus a month ago. At just 0.15% of the free float, short interest is functionally trivial — this is not a heavily shorted name. The sharp reduction in shorts coincides with the CTB collapse: as the squeeze pressure that built through April unwound, shorts covered and lending conditions eased simultaneously. Days to cover runs at just 0.015 days on the FINRA fortnightly figure, confirming the position is minimal. The short score of 54, up from the low-40s a fortnight ago, reflects the borrow cost remaining elevated rather than any meaningful positional pressure.
The price action tells a different story from the easing borrow dynamics. JZ closed at $0.73 on May 12, down 19.6% on the week and 13.6% over the month. The stock is down nearly 29% year-to-date. The RSI14 at 41 points toward oversold territory without yet triggering a classic reversal signal. With a market cap below $11 million, this is a micro-cap operating in a thin trading environment where small volume shifts can drive outsized price moves. The most recent earnings event on April 24 produced a one-day drop of 12.8% and a five-day follow-through loss of nearly 13% — a pattern worth noting given the stock's current trajectory.
Institutional coverage is sparse. The disclosed holder list is led by insiders — Peixuan Wang at 6.7% and Meiliang Li at 2.3% — with Citadel Advisors the only identifiable institutional name at a 0.12% stake, having trimmed 2,423 shares in its last reported period. No analyst coverage or price target data is available. The FY2025 results are flagged for September 25, with the April 13 annual filing (Form 20-F) the most recent disclosure event on record.
The central tension to watch is whether the borrow normalisation continues or re-tightens if price pressure draws fresh short interest back into the name — and whether the annual results filing generates any re-rating of a stock that has shed nearly a third of its value since January.
See the live data behind this article on ORTEX.
Open JZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
